Like so many other pharmacists I,too,read the letters in the PJ (25 October 2003,p578,1 November 2003,p612 and 20/27 December 2003,p841) about the transition of Tritace capsules to tablets.At first I was dubious as to the motives for the switch (I can be as cynical as the next man),however on further enquiry I was told by Aventis the rason for the switch was "to reduce production cost in htis country by brngng England in line with othe rEuropean countries where tablets are the norm".
展开▼
